Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00619_DB00864> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00619_DB00864 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00619_DB00864 label "DDI between Imatinib and Tacrolimus - The strong CYP3A4 inhibitor, Imatinib, may decrease the metabolism and clearance of Tacrolimus, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Tacrolimus if Imatinib is initiated, discontinued or dose changed. [drugbank_resource:DB00619_DB00864]" assertion.
- drugbank_resource:DB00619_DB00864 identifier "drugbank_resource:DB00619_DB00864" assertion.
- drugbank_resource:DB00619_DB00864 title "DDI between Imatinib and Tacrolimus - The strong CYP3A4 inhibitor, Imatinib, may decrease the metabolism and clearance of Tacrolimus, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Tacrolimus if Imatinib is initiated, discontinued or dose changed." assertion.